Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT02955199 Completed - Parenting Clinical Trials

Stage III Community-based Efficacy Trial for Mothering From the Inside Out

Start date: April 2015
Phase: N/A
Study type: Interventional

This is a Stage III community-based randomized clinical efficacy trial testing Mothering from the Inside Out (MIO), the first evidence-based parenting intervention designed to be delivered by addiction counselors in addiction treatment settings where parents of young children are enrolled in treatment.

NCT ID: NCT02954679 Completed - Clinical trials for Substance-related Disorder

French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students

ENQUETE-COSYS
Start date: January 23, 2017
Phase:
Study type: Observational

This descriptive and declarative study will help to find out consumption rates, all psychoactive substances taken together, among 18-25 year olds. More specifically, it will allow assessment of the extent of the cognitive enhancement phenomenon among students in France (including study of misuse of methylphenidate (MPH) and modafinil in improvement of cognitive performance).

NCT ID: NCT02951455 Completed - Clinical trials for Substance Use Disorders

Community Wise: An Innovative Multi-level Intervention to Reduce Alcohol and Illegal Drug Use

Start date: January 17, 2017
Phase: N/A
Study type: Interventional

The current project seeks to implement the Multiphase Optimization Strategy (MOST) and Community Based Participatory Research (CBPR) principles to identify the most efficient, scalable, and sustainable combination of Community Wise components. Community Wise is a manualized multi-level intervention aimed at reducing health inequalities related to alcohol and illicit drug use (AIDU).This 2x2x2x2 factorial design will be fully powered to detect change in AIDU in a sample of 528 men with substance use disorders and a history of incarceration residing in distressed communities with predominantly Black populations. Participants will be randomly assigned to one of sixteen experimental conditions.

NCT ID: NCT02951143 Completed - Clinical trials for Substance-Related Disorders

Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace

Start date: January 2017
Phase: N/A
Study type: Interventional

Tobacco regulatory policies can have unanticipated consequences; therefore, methods that would permit prospective estimates of the effects of potential tobacco regulations are necessary for the development of tobacco regulatory science. The goal of this project is to experimentally assess how smokers purchase and consume reduced-nicotine cigarettes. In experiment 1, we will investigate how purchasing/consuming reduced-nicotine cigarettes is related to nicotine content and absorption. In experiment 2, we will investigate how purchasing/consuming changes when other nicotine products are available in an experimental marketplace setting. The proposed projects can directly inform tobacco regulation by providing estimates of the real-world effects of novel policies.

NCT ID: NCT02950376 Completed - Clinical trials for Amphetamine Addiction

The Novel Addiction Assessment Study in Synthetic Drugs Addiction

Start date: December 2016
Phase:
Study type: Observational

The purpose of this research is to develop an objective assessment based on the virtual reality techniques which is used for evaluate addiction severity.

NCT ID: NCT02948868 Recruiting - Substance Addiction Clinical Trials

Combating Craving With Contingency Management: Neuroplasticity and Methamphetamine Abuse in South Africa

CM
Start date: January 2016
Phase: N/A
Study type: Interventional

This study will correlate MA-abstinence outcomes from an 8-week contingency management (CM) program of voucher- based incentives using an escalating schedule that has been successfully implemented as an adjunct to MA treatment by the investigators collaborators in the United States. Pre- and post- treatment neuroimaging and neurocognitive assessments will assist in identifying structures and/or processes that may represent targets for development of novel behavioral and/or medication therapies.

NCT ID: NCT02945436 Completed - HIV Clinical Trials

Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention

Swerve
Start date: April 7, 2017
Phase: N/A
Study type: Interventional

A sample of 300 young (15-29) men who have sex with men (MSM) and transgender persons living in South-East Michigan's Detroit Metro Area (DMA) will be recruited through venue-based sampling and online ads to examine the efficacy of adding a substance use brief intervention (SUBI) to standard HIV prevention and care (SOC) for achieving gains in successful engagement in HIV care. The investigators will partner with Detroit-area AIDS Service Organizations (ASOs) to deliver the intervention.

NCT ID: NCT02945371 Completed - Smoking Clinical Trials

Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life

REV
Start date: September 2014
Phase: N/A
Study type: Interventional

Insufficient inhibitory control is one pathway through which early adversity is related to a range of problems including excessive alcohol use, tobacco use, and unhealthy eating. The proposed research leverages a neurally informed model of inhibitory control and how it can be improved to test the efficacy of a person-centered inhibitory control intervention in a sample of mid-life individuals with early adversity. The knowledge obtained by this study could be scaled into a flexible, low-cost, and wide-ranging intervention to remediate some of the effects of early adversity on inhibitory control and thus a number of prevalent health risking behaviors.

NCT ID: NCT02943408 Completed - Depression Clinical Trials

Development of a Patient Centered Mental Health Intervention for Recent Veterans

PCC MH
Start date: July 31, 2017
Phase: N/A
Study type: Interventional

Recent Veterans of the OIF/OEF/OND conflicts are presenting in VA care with high rates of: PTSD, depression, anxiety, and alcohol abuse, reporting significant difficulties with community reintegration, and dropping out of mental health care at high rates. Surveys of recent Veterans show that Veterans want the VA to provide mental health care tailored to their concerns and reintegration priorities. The VA is committed to providing personalized, proactive, patient centered care (PCC); but little research or intervention development has been done on PCC in mental health care settings and preliminary research indicates Veterans may lack the skills and knowledge to be active partners in PCC. This study aims to examine PCC behaviors in VA mental health care and, informed by this data, develop a brief patient centered mental health intervention that will help recent Veterans take the lead in their care personalization and support their functional recovery. Results from this study will demonstrate the acceptability, feasibility, and preliminary efficacy of this intervention.

NCT ID: NCT02942979 Completed - Mental Illness Clinical Trials

Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking

MISSION-HPACT
Start date: February 12, 2016
Phase:
Study type: Observational [Patient Registry]

This study seeks to implement wrap around services for Veterans suffering from co-occurring mental illness and substance use and who are homeless. It will compare Implementation as Usual of MISSION to Facilitation Implementation of MISSION.